About
Mo Ebrahimkhani is a synthetic biology and regenerative medicine researcher best known publicly as co-founder and CSO of HexemBio. HexemBio describes him as the inventor of the company's core blood stem-cell rejuvenation technology, and a 2024 Nature paper lists him as corresponding author with multiple University of Pittsburgh affiliations. His public profile is that of a scientist-entrepreneur and academic research leader rather than an investor or fund manager.
Areas of interest
longevitybiotechregenerative medicinesynthetic biologystem cellshematologycell therapyaging biologyAI in biotech